Today before the opening bell, Cardium Therapeutics announced that Chairman & CEO Christopher J. Reinhard will be presenting at the BioX Noble Financial Life Sciences Exposition being held at the University of Connecticut, Stamford Campus on September 24 - 25, 2012.
A video webcast of the presentation, along with a copy of the slide deck, will be available shortly after the conference on Thursday, September 27, 2012, at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar, as well as through the Noble Financial website at www.noblefcm.com. Microsoft SilverLight viewer will need to be installed to participate. The investor presentation is now available at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.
Cardium Therapeutics is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
To learn more about the company, visit www.cardiumthx.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html